Discover investment opportunities in Hearing Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Hearing Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Hearing Stocks using our Smart AI Filter.
6 stocks found for "Hearing Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.74 | ±35.8% | 14.4 | 0.00% | |||
0.83 | ±27.4% | 23.5 | 3.08% | |||
0.41 | ±18.7% | 37.4 | 0.00% | |||
0.36 | ±21.7% | 15.1 | 3.17% | |||
0.98 | ±39.0% | 19.2 | 0.00% | |||
1.00 | ±35.9% | 31.3 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: What opportunities do hearing aid companies like Sonova Holding AG (SONVY) present?
A: Sonova Holding AG (SONVY), a leader in hearing care solutions, benefits from an aging global population, driving demand for hearing aids. The company leverages advanced audiological technologies and global distribution networks, appealing to growth-focused investors.
Q: How might regulatory changes impact Audentes Therapeutics (ADHE)?
A: Regulatory approvals or modifications significantly affect biopharmaceutical firms like Audentes Therapeutics (ADHE). Changes can influence drug development timelines, market entry, and revenue potential, requiring close monitoring of FDA and EMA guidelines.
Q: What makes GN Store Nord A/S (GNDC) appealing for growth investors?
A: GN Store Nord A/S (GNDC) appeals to growth investors due to its innovative audio solutions, including wireless and hearing technology, supported by strong R&D investments and potential to tap into expanding global markets.
Q: Does Watsco, Inc. (WSO) offer dividend income potential?
A: Watsco, Inc. (WSO) is known for consistent dividend payouts, appealing to income-oriented investors. The company's stability in the HVAC distribution sector supports sustainable dividend practices, though investors should review its payout ratio.
Q: What sector-specific risks are associated with Hibbett Sports, Inc. (HIBB)?
A: Hibbett Sports, Inc. (HIBB) faces sector-specific risks like fluctuating consumer spending in athletic retail and competition from e-commerce platforms. Investors should consider these risks in market downturns and technological shifts.
Q: How does HitecVision (HITR) navigate economic cycles?
A: HitecVision (HITR), investing in energy solutions, shows resilience through economic cycles by focusing on energy transition projects. However, oil price volatility and regulatory shifts can impact its investment sustainability.